These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4198846)

  • 21. What role does the measurement of fibrinogen and its derivatives have in the diagnosis of disseminated intravascular coagulation?
    Dempfle CE
    Blood Rev; 2002 Dec; 16 Suppl 1():S23-8. PubMed ID: 12918784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
    J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fibronectin and fibrinogen/fibrin at the focus of an experimental myocardial infarct].
    Shekhonin BV; Guriev SB; Irgashev ShB; Kotelianskiĭ VE
    Arkh Patol; 1989; 51(9):14-20. PubMed ID: 2688595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fibrinogen and fibrin degradation products (FDP) in serum of patients with acute myocardial infarct and with imminent infarct].
    Kedra M; Kutarski A; Dmoxzyńska A
    Pol Tyg Lek; 1975 Sep; 30(37):1517-21. PubMed ID: 1161615
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrin degradation products in acute myocardial infarction.
    Arya TV; Goel VK; Mehrotra TN; Singh VS; Rajvanshi S; Raka MS
    J Assoc Physicians India; 1983 Nov; 31(11):691-2. PubMed ID: 6671945
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficiency and limits of laboratory diagnosis of diffuse intravascular blood coagulation processes].
    Heene DL; Lasch HG
    Internist (Berl); 1973 Apr; 14(4):154-9. PubMed ID: 4268495
    [No Abstract]   [Full Text] [Related]  

  • 27. Are fibrin-related markers useful for the diagnosis of thrombosis?
    Wada H; Sakuragawa N
    Semin Thromb Hemost; 2008 Feb; 34(1):33-8. PubMed ID: 18393141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
    Thuot C; Perron L
    Union Med Can; 1973 Jan; 102(1):66-9. PubMed ID: 4706340
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Dempfle CE
    Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of 125I-fibrinogen kinetic data to detect disseminated intravascular coagulation and deposition of fibrin in patients with metastatic cancer.
    Robson EB; Murawski GF; Bettigole RE
    Thromb Haemost; 1977 Jun; 37(3):484-508. PubMed ID: 578029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of fibrin trapping in the lungs of patients developing the microembolism syndrome. A preliminary report.
    Busch C; Dahlgren S; Jacobsson S; Jung B; Modig J; Saldeen T
    Acta Chir Scand; 1971; 137(7):599-601. PubMed ID: 5149145
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrin degradation products and the 125I-labeled fibrinogen test in patients with myocardial infarction.
    Morris GK; Hayes MJ; Hampton JR
    Eur J Cardiol; 1974 Aug; 2(1):35-8. PubMed ID: 4472114
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum fibrin-fibrinogen degradation products in acute myocardial infarction.
    Almer LO; Hedner U; Nilsson IM
    Lancet; 1972 Apr; 1(7757):960. PubMed ID: 4112124
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lipids and fibrin-fibrinogen degradation products levels in the serum in acute myocardial infarct].
    Kutarski A; Dmoszyńska A; Rymar B; Staśkiewicz J
    Pol Tyg Lek; 1976 Apr; 31(14):565-8. PubMed ID: 1272944
    [No Abstract]   [Full Text] [Related]  

  • 36. [Erythrocyte equidistance and heavy metals in the pathogenesis of disseminated intravascular coagulation in myocardial infarct patients at the hospital rehabilitation stage].
    Solov'ev AV; Ermolin GA; Soroka VR
    Lik Sprava; 1993; (10-12):30-4. PubMed ID: 8030303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of fibrin deposition and elimination in organs of rats injected with labelled fibrinogen by isolation of the labelled fibrin from water soluble tracer.
    Busch C; Rammer L
    Thromb Diath Haemorrh; 1973 Feb; 29(1):108-14. PubMed ID: 4708588
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of thrombin-induced fibrinogen derivatives in thrombotic states.
    Heene DL; Matthias FR
    Bibl Haematol; 1977; 44():161-8. PubMed ID: 617780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated intravascular coagulation and a negative D-dimer test.
    Constantinescu AA; Berendes PB; Levin MD
    Neth J Med; 2007 Nov; 65(10):398-400. PubMed ID: 18057464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.